eF-site ID 6c4j-E
PDB Code 6c4j
Chain E

click to enlarge
Title Ligand bound full length hUGDH with A104L substitution
Classification OXIDOREDUCTASE
Compound UDP-glucose 6-dehydrogenase
Source (UGDH_HUMAN)
Sequence E:  MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNES
RINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIK
EADLVFISVNTPTKTYGMGKGRALDLKYIEACARRIVQNS
NGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNP
EFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYE
HWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISAL
CEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKD
VLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIID
SLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDE
GAHLHIYDPKVPREQIVVDLSHDQVSRLVTISKDPYEACD
GAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLD
GLHNELQTIGFQIETIGKKV
Description


Functional site

1) chain E
residue 10
type
sequence I
description binding site for residue NAD E 501
source : AD8

2) chain E
residue 11
type
sequence G
description binding site for residue NAD E 501
source : AD8

3) chain E
residue 13
type
sequence G
description binding site for residue NAD E 501
source : AD8

4) chain E
residue 14
type
sequence Y
description binding site for residue NAD E 501
source : AD8

5) chain E
residue 15
type
sequence V
description binding site for residue NAD E 501
source : AD8

6) chain E
residue 36
type
sequence D
description binding site for residue NAD E 501
source : AD8

7) chain E
residue 37
type
sequence V
description binding site for residue NAD E 501
source : AD8

8) chain E
residue 41
type
sequence R
description binding site for residue NAD E 501
source : AD8

9) chain E
residue 88
type
sequence S
description binding site for residue NAD E 501
source : AD8

10) chain E
residue 89
type
sequence V
description binding site for residue NAD E 501
source : AD8

11) chain E
residue 90
type
sequence N
description binding site for residue NAD E 501
source : AD8

12) chain E
residue 91
type
sequence T
description binding site for residue NAD E 501
source : AD8

13) chain E
residue 108
type
sequence Y
description binding site for residue NAD E 501
source : AD8

14) chain E
residue 130
type
sequence S
description binding site for residue NAD E 501
source : AD8

15) chain E
residue 131
type
sequence T
description binding site for residue NAD E 501
source : AD8

16) chain E
residue 161
type
sequence E
description binding site for residue NAD E 501
source : AD8

17) chain E
residue 279
type
sequence K
description binding site for residue NAD E 501
source : AD8

18) chain E
residue 162
type
sequence F
description binding site for residue UPG E 502
source : AD9

19) chain E
residue 163
type
sequence L
description binding site for residue UPG E 502
source : AD9

20) chain E
residue 164
type
sequence A
description binding site for residue UPG E 502
source : AD9

21) chain E
residue 165
type
sequence E
description binding site for residue UPG E 502
source : AD9

22) chain E
residue 220
type
sequence K
description binding site for residue UPG E 502
source : AD9

23) chain E
residue 224
type
sequence N
description binding site for residue UPG E 502
source : AD9

24) chain E
residue 231
type
sequence I
description binding site for residue UPG E 502
source : AD9

25) chain E
residue 265
type
sequence F
description binding site for residue UPG E 502
source : AD9

26) chain E
residue 266
type
sequence L
description binding site for residue UPG E 502
source : AD9

27) chain E
residue 267
type
sequence K
description binding site for residue UPG E 502
source : AD9

28) chain E
residue 269
type
sequence S
description binding site for residue UPG E 502
source : AD9

29) chain E
residue 272
type
sequence F
description binding site for residue UPG E 502
source : AD9

30) chain E
residue 273
type
sequence G
description binding site for residue UPG E 502
source : AD9

31) chain E
residue 276
type
sequence C
description binding site for residue UPG E 502
source : AD9

32) chain E
residue 277
type
sequence F
description binding site for residue UPG E 502
source : AD9

33) chain E
residue 338
type
sequence F
description binding site for residue UPG E 502
source : AD9

34) chain E
residue 339
type
sequence K
description binding site for residue UPG E 502
source : AD9

35) chain E
residue 442
type
sequence R
description binding site for residue UPG E 502
source : AD9

36) chain E
residue 135
type
sequence R
description binding site for residue SO4 E 503
source : AE1

37) chain E
residue 214
type
sequence W
description binding site for residue SO4 E 503
source : AE1

38) chain E
residue 162
type
sequence F
description binding site for residue PGO E 504
source : AE2

39) chain E
residue 171
type
sequence D
description binding site for residue PGO E 504
source : AE2

40) chain E
residue 176
type
sequence D
description binding site for residue PGO E 504
source : AE2

41) chain E
residue 177
type
sequence R
description binding site for residue PGO E 504
source : AE2

42) chain E
residue 260
type
sequence R
description binding site for residue UPG F 502
source : AE4

43) chain E
residue 465
type
sequence K
description binding site for residue SO4 F 504
source : AE6

44) chain E
residue 258
type
sequence D
description binding site for residue PGO F 505
source : AE7

45) chain E
residue 220
type ACT_SITE
sequence K
description Proton donor/acceptor => ECO:0000269|PubMed:22123821
source Swiss-Prot : SWS_FT_FI1

46) chain E
residue 161
type ACT_SITE
sequence E
description Proton donor/acceptor => ECO:0000269|PubMed:22123821
source Swiss-Prot : SWS_FT_FI1

47) chain E
residue 276
type ACT_SITE
sequence C
description Nucleophile => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21984906, ECO:0000269|PubMed:22123821
source Swiss-Prot : SWS_FT_FI2

48) chain E
residue 11
type BINDING
sequence G
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

49) chain E
residue 36
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

50) chain E
residue 41
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

51) chain E
residue 89
type BINDING
sequence V
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

52) chain E
residue 276
type BINDING
sequence C
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI3

53) chain E
residue 130
type BINDING
sequence S
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445
source Swiss-Prot : SWS_FT_FI4

54) chain E
residue 161
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

55) chain E
residue 220
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

56) chain E
residue 267
type BINDING
sequence K
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

57) chain E
residue 338
type BINDING
sequence F
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI5

58) chain E
residue 165
type BINDING
sequence E
description BINDING => ECO:0000269|PubMed:21502315, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4
source Swiss-Prot : SWS_FT_FI6

59) chain E
residue 107
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI10

60) chain E
residue 260
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:23106432, ECO:0000269|PubMed:27966912, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF, ECO:0007744|PDB:5TJH
source Swiss-Prot : SWS_FT_FI7

61) chain E
residue 346
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:21502315, ECO:0000269|PubMed:21595445, ECO:0000269|PubMed:21984906, ECO:0000269|PubMed:22123821, ECO:0007744|PDB:2Q3E, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:3TDK
source Swiss-Prot : SWS_FT_FI8

62) chain E
residue 442
type BINDING
sequence R
description BINDING => ECO:0000269|PubMed:22123821, ECO:0000269|PubMed:23106432, ECO:0000305|PubMed:21502315, ECO:0000305|PubMed:21595445, ECO:0007744|PDB:2QG4, ECO:0007744|PDB:3KHU, ECO:0007744|PDB:3PRJ, ECO:0007744|PDB:3PTZ, ECO:0007744|PDB:4EDF
source Swiss-Prot : SWS_FT_FI9


Display surface

Download
Links